Trial Profile
Phase 1, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XPF-001 and to Investigate the Effect of Food on the Pharmacokinetics of a Single Dose of XPF-001 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2009
Price :
$35
*
At a glance
- Drugs Funapide (Primary)
- Indications Pain
- Focus Adverse reactions
- 11 Nov 2009 New trial record